Electrolyte Disturbances in Critically Ill Cancer Patients: An Endocrine Perspective.

Link to article at PubMed

Related Articles

Electrolyte Disturbances in Critically Ill Cancer Patients: An Endocrine Perspective.

J Intensive Care Med. 2018 Mar;33(3):147-158

Authors: Khan MI, Dellinger RP, Waguespack SG

Abstract
Electrolyte disturbances are frequently encountered in critically ill oncology patients. Hyponatremia and hypernatremia as well as hypocalcemia and hypercalcemia are among the most commonly encountered electrolyte abnormalities. In the intensive care unit, management of critical electrolyte disturbances is focused on initial evaluation and immediate treatment plan to prevent severe complications. A PubMed search was performed to identify best available evidence for evaluation and management of dysnatremias, hypocalcemia, and hypercalcemia. Current literature was reviewed regarding the management of electrolyte disturbances. The role of new therapeutic options, for example, vaptans for hyponatremia, teriparatide for hypocalcemia, and denosumab for hypercalcemia, is discussed. Early diagnosis and appropriate management are expected to reduce adverse outcomes.

PMID: 28535742 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published.